Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lisa L Ross

Fosamprenavir or Atazanavir Once Daily Boosted With Ritonavir 100mg, Plus Tenofovir/Emtricitabine, for the Initial Treatment of HIV Infection: 48-Week Results of ALERT

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2008English

Related publications

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

New England Journal of Medicine
Medicine
2009English

Maraviroc 150 Mg Daily Plus Lopinavir/Ritonavir, a Nucleoside/Nucleotide Reverse Transcriptase Inhibitor-Sparing Regimen for HIV-infected Naive Patients: 48-Week Final Results of VEMAN Study

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Resistance Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment-Naïve Patients Through 48 Weeks

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy